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Correspondence Regression of “Gray Zone” Exercise-Induced
Concentric Left Ventricular Hypertrophy
During Prescribed DetrainingTo the Editor: Left ventricular hypertrophy (LVH) may develop in
response to exercise training. In extreme cases, exercise-induced LVH
(EI-LVH) may be difficult to differentiate from clinically relevant
conditions such as hypertrophic cardiomyopathy (HCM). A valuable
clinical pathway integrating aspects of the medical history, physical
examination, 12-lead electrocardiogram (ECG), and noninvasive
imaging has been developed for determining the etiology of such
“gray-zone” hypertrophy (1). Although this algorithm is useful, it does
ot always produce a definitive diagnosis. In cases that remain
mbiguous, prescribed detraining is recommended (2).
The geometry of EI-LVH is variable with endurance/isotonic
exercise leading to eccentric hypertrophy and strength/isometric
exercise leading to concentric hypertrophy. Eccentric EI-LVH,
balanced chamber enlargement and wall thickening, is typically
distinct from HCM. In contrast, concentric EI-LVH, character-
ized by increased relative wall thickness, is morphologically similar
to HCM. Thus, the significance of concentric LVH among
athletic patients is often a source of clinical uncertainty. Prior
studies documenting the regression of LVH following detraining
have largely examined elite athletes with eccentric EI-LVH over
variable time periods of detraining (3,4), leaving the response to
detraining among athletes with concentric EI-LVH incompletely
understood. We therefore examined the myocardial response to 6
months of prescribed detraining among a group of collegiate male
football players with “gray-zone” concentric EI-LVH.
Participants were recruited from the Harvard Athlete Initiative,
a longitudinal program designed to evaluate myocardial structure
and function among collegiate athletes. Eligibility criteria for this
study included: 1) normal cardiac structure without LVH at the
time of university matriculation; 2) concentric EI-LVH at the
immediate conclusion of the 4-year collegiate athletic career; and
3) willingness to participate in a prescribed detraining program.
Eligible participants completed a 6-month period of prescribed
detraining during which exercise training was limited to 2
hr/week. None of the participants took anabolic steroids during
their college athletic careers and none reported taking any medi-
cations during the detraining period. Twelve-lead ECGs were
obtained on all athletes at all time points. ECG voltage was
quantified by the summation of the R- and S-wave voltages in all
precordial leads as previously described (3). Parameters of left
ventricular (LV) structure were assessed by 2-dimensional echo-
cardiography (Vivid-I, General Electric, Milwaukee, Wisconsin)
at 4 time points: college matriculation (baseline), completion of
competitive collegiate football (peak fitness), and after 3 and 6
months of detraining. Concentric LVH was defined as LV wall
thickness 12 mm, LV mass 126 g/m (5), and relative wall
thickness 0.42. Echocardiographic measurements were made
by study investigators (R.B.W., A.L.B.) blinded to study timepoint. Correlation coefficients (r2) defining interobserver vari-
ability (simple linear regression) were 0.963 and 0.959 for LV
wall thickness and mass, respectively. Repeated measures anal-
ysis of variance with Bonferroni’s multiple comparison correc-
tion was used to assess significance of interval changes across
study time points.
Five males (age 21  1 year, height 1.9  0.07 m) met
eligibility criteria and completed the detraining protocol. Each
individual had normal cardiac structure (LV mass 113  8 g/m,
LV wall thickness 10.5  0.5 mm) upon college matriculation and
demonstrated concentric EI-LVH at the completion of collegiate
athletics (LV mass 139  7 g/m, p  0.001; LV wall thickness
12.4  0.5 mm, p  0.001). Systolic blood pressure declined from
peak training through 6 months of detraining (peak 137  10 mm
Hg vs. 3 months 109  9 mm Hg vs. 6 months 108  6 mm Hg,
p  0.001) while diastolic blood pressure and body mass were
unchanged.
Significant regression of LV mass, LV wall thickness, and left
atrial size occurred during detraining (Fig. 1). Although regression
was observed at 3 months, 6 months was required for complete
normalization of all cardiac parameters. Additionally, there was a
trend toward an increase in LV diastolic dimension after detrain-
ing (peak 52.4 mm vs. 6 months 53.9 mm, p 0.08). Comparison
of ECG voltage across the detraining period showed a trend
toward voltage regression (peak 132 28 mm vs. 3 months 122
21 vs. 6 months 119  19 mm, p  0.09).
Prior studies examining the LV response to exercise cessation
have focused on eccentric EI-LVH and have not standardized the
duration of detraining. Maron et al. documented regression of
eccentric EI-LVH among Olympic athletes over 6 to 34 weeks
(mean 13 weeks) (3). The largest detraining report included 40
elite Italian male athletes with eccentric LVH (LV dimension
61.2  2.9 mm, LV wall thickness 12.0  1.3 mm) (4). These
athletes demonstrated complete normalization of wall thickness
and significant but incomplete reduction in cavity dilation after
5.8  3.6 years of detraining.
Data defining the response of concentric EI-LVH, the geomet-
ric form that most closely resembles HCM, to prescribed exercise
cessation are lacking. Thus, clinical implementation of prescribed
detraining in this setting is problematic for several reasons. First,
there are insufficient data documenting the extent of regression of
concentric EI-LVH. Second, the time required for clinically
meaningful detraining remains unknown. The present study pro-
vides novel data that address both of these issues. We have shown
that concentric EI-LVH is a dynamic process that can regress fully
following removal of the training stimuli. In addition, we have
shown that 6 months of detraining may be necessary to produce
complete normalization of LV structure.
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May 29, 2012:1992–4Pathologic LVH, most commonly HCM, is an important cause
of sudden cardiac death among young competitive athletes, while
EI-LVH is considered to be a benign physiological phenomenon.
Thus, the assessment of the athlete with LVH of indeterminate
etiology is a task with important clinical implications. Although
clinical assessment combined with noninvasive imaging is often
capable of differentiating pathologic from EI-LVH, prescribed
detraining is necessary in some cases. Findings from the present
study may assist clinicians contemplating a detraining directive by
providing data documenting the time course and completeness of
concentric LVH regression.
There are limitations of this study. First, we studied a small
number of athletes and further confirmatory work is warranted.
Second, we studied relatively young athletes and are thus unable
to comment about whether our observations can be applied to
older individuals with more extensive prior exercise exposure.
Nonetheless, we studied National Collegiate Athletic Associa-
tion athletes, a large population in which the clinical dilemma
of distinguishing physiologic from pathologic hypertrophy oc-
curs with relatively high frequency. Finally, the use of cardiac
magnetic resonance in addition to echocardiography may allow
for more precise quantification of changes in LV wall thickness
Figure 1 Left Ventricular and Left Atrial Changes With Exercise Training
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